Disease | Therapeutics | WHO
No link between two ongoing Ebola outbreaks in the Democratic Republic of the Congo
On Jun. 9, 2020, new genetic sequence analysis by the Democratic Republic of the Congo’s (DRC) National Institute…
Up to 45 percent of SARS-CoV-2 infections may be asymptomatic, new analysis found
On Jun. 9, 2020, a Scripps research analysis of public datasets on asymptomatic infections, an extraordinary percentage of…
Immunic announced FDA allowance of its phase 2, CALVID-1 clinical trial of IMU-838 in COVID-19
On Jun. 9, 2020, Immunic announced receipt of regulatory allowance from the FDA to initiate its phase 2,…
Emergency COVID-19 measures prevented more than 500 million infections
On Jun. 8, 2020, Emergency health measures implemented in six major countries have ﾓsignificantly and substantially slowedﾔ the…
FibroGen announced first patient enrolled in Pamrevlumab clinical trial in patients hospitalized in Italy with severe COVID-19
On Jun. 8, 2020, FibroGen announced the initiation of an open-label, randomized, parallel-arm study investigating the efficacy and…
Calquence showed promising clinical improvement in majority of 19 hospitalised COVID-19 patients
On Jun. 5, 2020, results were published in Science Immunology showed that Calquence (acalabrutinib), a Brutonﾒs tyrosine kinase…
Sorrento announced COVIDTRAP(STI-4398) demonstrated in preclinical studies its ability to completely inhibit SARS-CoV-2 viral infection In vitro
On Jun. 5, 2020, Sorrento announced it had completed a preclinical batch of the STI-4398 (COVIDTRAP) protein and…
HPV vaccine manufacturers commited to provide enough supply to immunise at least 84 million girls in Gavi countries
On Jun. 4, 2020, vaccine manufacturers MSD, GSK, Innovax, Serum Institute of India and Walvax pledged to ramp…
COVID-19 | Diagnostics | NIH
HHS announced new laboratory data reporting guidance for COVID-19 testing
On Jun. 4, 2020, the U.S. Department of Health and Human Services (HHS) announced new Guidance that specified…
HPV vaccine manufacturers committed to immunise at least 84 million girls in Gavi countries
On Jun. 4, 2020, vaccine manufacturers MSD, GSK, Innovax, Serum Institute of India (SII) and Walvax pledged to…
Introduction and spread of SARS-CoV-2 in the greater Boston area
On Jun. 4, 2020, data from the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the…
CEPI granted $141 million to consortium of Bharat Biotech and IVI to advance development of Chikungunya vaccine in collaboration with Ind-CEPI
On Jun. 3, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, in collaboration with Ind-CEPI, announced a new…
The USDA announced the first confirmed case of a dog in the US to test positive for SARS-CoV-2
On Jun. 2, 2020, the USDA announced the first confirmed case of SARS-CoV-2 (the virus that causes COVID-19)…
Albert Einstein College of Medicine awarded $1 million for COVID-19 research from the Price Family Foundation
On Jun. 2, 2020, Albert Einstein College of Medicine announced it had received a $1 million challenge grant…
Resverlogix announced COVID-19 clinical trial program launch
On Jun. 1, 2020, Resverlogix announced that it is moving forward with a plan to further evaluate apabetaloneﾒs…
New Ebola outbreak detected in northwest Democratic Republic of the Congo
On Jun. 1, 2020, the Government of the Democratic Republic of the Congo announced that a new outbreak…
The USDA announced transition to preventive plan for virulent Newcastle disease in California
On Jun. 1, 2020, the USDA announced it is transitioning its virulent Newcastle disease (vND) efforts in southern…
CIRM board approved three projects targeting COVID-19
On May 29, 2020, the California Institute for Regenerative Medicine (CIRM) approved investments in three early-stage research programs…
Moderna announced first participants in each age cohort dosed in phase 2 study of mRNA vaccine against novel Coronavirus
On May 29, 2020, Moderna announced the first participants in each age cohort had been dosed in the…
Johnson & Johnson received positive CHMP opinion for Janssen’s investigational preventive Ebola vaccine regimen
On May 29, 2020, Johnson & Johnson announced that its Janssen Pharmaceutical subsidiary received a positive opinion from…
The Jenner Institute signed agreement with Advent to develop a novel coronavirus vaccine
On May 28, 2020, the Jenner Institute, University of Oxford, UK and Advent Srl ﾖ an IRBM company,…
GSK announced intention to produce 1 billion doses of pandemic vaccine adjuvant in 2021 to support multiple COVID-19 vaccine collaborations
On May 28, 2020, GSK confirmed its intention to manufacture 1 billion doses of its pandemic vaccine adjuvant…
The US Dept of Veterans Affairs conducted deep-dive study into effects of COVID-19 on Veterans
On May 28, 2020, the U.S. Dept. of Veterans Affairs (VA) began a national four-year study on the…
IAVI and Merck announced collaboration to develop vaccine against SARS-CoV-2
On May 26, 2020, Merck and and IAVI, a nonprofit scientific research organization dedicated to addressing urgent, unmet…
Innovation Pharma receives data from public health research institute showing brilacidin inhibits SARS-CoV-2 (COVID-19) in human cell line
On May 26, 2020, Innovation Pharma reported receiving data from a leading public health research institute showing Brilacidin…
Novavax initiated phase 1/2 clinical trial of COVID-19 vaccine
On May 26, 2020, Novavax announced enrollment of the first participants in a Phase 1/2 clinical trial of…
Rice University COVID-19 research fund awarded final grants
On May 26, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it had awarded…
Analysis of COVID-19 genomes revealed large numbers of introductions to the UK in March, 2020
On May 22, 2020, data reports, published by the COVID-19 Genomics UK Consortium (COG-UK), showed the value in…
Innovation Pharma pursuing gold standard in battle gainst Covid-19
On May 21, 2020, Innovation Pharma announced that in vitro research independently conducted at a U.S. Regional Biocontainment…
ADMA Biologics commenced collection of COVID-19 plasma from recovered patients
On May 21, 2020, ADMA Biologics announced it had commenced the collection of convalescent plasma through its wholly-owned…